Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

41 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long-Term Effectiveness, Safety and Tolerability of Fingolimod in Patients with Multiple Sclerosis in Real-World Treatment Settings in France: The VIRGILE Study.
Papeix C, Castelnovo G, Leray E, Coustans M, Levy P, Visy JM, Kobelt G, Lamy F, Allaf B, Heintzmann F, Chouette I, Raponi E, Durand B, Grevat E, Kamar D, Debouverie M, Lebrun-Frenay C; Virgile Study Group. Papeix C, et al. Among authors: coustans m. Neurol Ther. 2022 Jun;11(2):633-658. doi: 10.1007/s40120-022-00334-y. Epub 2022 Feb 11. Neurol Ther. 2022. PMID: 35147904 Free PMC article.
Feasibility and benefits of home initiation of subcutaneous apomorphine infusion for patients with Parkinson's disease: the APOKADO study.
Zagnoli F, Leblanc A, Viakhireva-Dovganyuk I, Delabrousse-Mayoux JP, Pouyet A, Ziegler M, Sogni L, Patat M, Bouillot R, Vérin M; APOKADO Group. Zagnoli F, et al. J Neural Transm (Vienna). 2023 Nov;130(11):1463-1474. doi: 10.1007/s00702-023-02609-6. Epub 2023 Mar 2. J Neural Transm (Vienna). 2023. PMID: 36862190 Free PMC article.
Disease reactivation after fingolimod cessation in Multiple Sclerosis patients with pregnancy desire: A retrospective study.
Callens A, Leblanc S, Le Page E, Edan G, Jourdain A, Coustans M, Wiertlewski S, Laplaud D, Videt D, Lallement F, Leray E, Michel L. Callens A, et al. Among authors: coustans m. Mult Scler Relat Disord. 2022 Oct;66:104066. doi: 10.1016/j.msard.2022.104066. Epub 2022 Jul 22. Mult Scler Relat Disord. 2022. PMID: 35908450 Free article.
Cost-utility of oral methylprednisolone in the treatment of multiple sclerosis relapses: Results from the COPOUSEP trial.
Michel M, Le Page E, Laplaud DA, Wardi R, Lebrun C, Zagnoli F, Wiertlewski S, Coustans M, Edan G, Chevreul K, Veillard D; West Network for Excellence in Neuroscience; COPOUSEP investigators. Michel M, et al. Among authors: coustans m. Rev Neurol (Paris). 2022 Mar;178(3):241-248. doi: 10.1016/j.neurol.2021.06.009. Epub 2021 Sep 28. Rev Neurol (Paris). 2022. PMID: 34598781 Clinical Trial.
DMTs and Covid-19 severity in MS: a pooled analysis from Italy and France.
Sormani MP, Salvetti M, Labauge P, Schiavetti I, Zephir H, Carmisciano L, Bensa C, De Rossi N, Pelletier J, Cordioli C, Vukusic S, Moiola L, Kerschen P, Radaelli M, Théaudin M, Immovilli P, Casez O, Capobianco M, Ciron J, Trojano M, Stankoff B, Créange A, Tedeschi G, Clavelou P, Comi G, Thouvenot E, Battaglia MA, Moreau T, Patti F, De Sèze J, Louapre C; Musc-19; Covisep study groups. Sormani MP, et al. Ann Clin Transl Neurol. 2021 Aug;8(8):1738-1744. doi: 10.1002/acn3.51408. Epub 2021 Jul 7. Ann Clin Transl Neurol. 2021. PMID: 34240579 Free PMC article.
Longitudinally Extensive Myelitis Associated With Immune Checkpoint Inhibitors.
Picca A, Berzero G, Bihan K, Jachiet V, Januel E, Coustans M, Cauquil C, Perrin J, Berlanga P, Kramkimel N, Garel B, Devic P, Ducray F, Benazra M, Bompaire F, Leclercq D, Michot JM, Ammari S, Psimaras D. Picca A, et al. Among authors: coustans m. Neurol Neuroimmunol Neuroinflamm. 2021 Feb 26;8(3):e967. doi: 10.1212/NXI.0000000000000967. Print 2021 May. Neurol Neuroimmunol Neuroinflamm. 2021. PMID: 33637598 Free PMC article.
Urinary tract infections and multiple sclerosis: Recommendations from the French Multiple Sclerosis Society.
Donzé C, Papeix C, Lebrun-Frenay C; French Group for Recommendations in Multiple Sclerosis (France4MS); Société francophone de la sclérose en plaques (SFSEP); SPILF; Co-chairs; Supervision of the readers; Readers; Rating group; Reading group. Donzé C, et al. Rev Neurol (Paris). 2020 Dec;176(10):804-822. doi: 10.1016/j.neurol.2020.02.011. Epub 2020 Sep 5. Rev Neurol (Paris). 2020. PMID: 32900473
Clinical Characteristics and Outcomes in Patients With Coronavirus Disease 2019 and Multiple Sclerosis.
Louapre C, Collongues N, Stankoff B, Giannesini C, Papeix C, Bensa C, Deschamps R, Créange A, Wahab A, Pelletier J, Heinzlef O, Labauge P, Guilloton L, Ahle G, Goudot M, Bigaut K, Laplaud DA, Vukusic S, Lubetzki C, De Sèze J; Covisep investigators; Derouiche F, Tourbah A, Mathey G, Théaudin M, Sellal F, Dugay MH, Zéphir H, Vermersch P, Durand-Dubief F, Françoise R, Androdias-Condemine G, Pique J, Codjia P, Tilikete C, Marcaud V, Lebrun-Frenay C, Cohen M, Ungureanu A, Maillart E, Beigneux Y, Roux T, Corvol JC, Bordet A, Mathieu Y, Le Breton F, Boulos DD, Gout O, Guéguen A, Moulignier A, Boudot M, Chardain A, Coulette S, Manchon E, Ayache SS, Moreau T, Garcia PY, Kumaran D, Castelnovo G, Thouvenot E, Taithe F, Poupart J, Kwiatkowski A, Defer G, Derache N, Branger P, Biotti D, Ciron J, Clerc C, Vaillant M, Magy L, Montcuquet A, Kerschen P, Coustans M, Guennoc AM, Brochet B, Ouallet JC, Ruet A, Dulau C, Wiertlewski S, Berger E, Buch D, Bourre B, Pallix-Guiot M, Maurousset A, Audoin B, Rico A, Maarouf A, Edan G, Papassin J, Videt D. Louapre C, et al. Among authors: coustans m. JAMA Neurol. 2020 Sep 1;77(9):1079-1088. doi: 10.1001/jamaneurol.2020.2581. JAMA Neurol. 2020. PMID: 32589189 Free PMC article.
Neuraxial analgesia is not associated with an increased risk of post-partum relapses in MS.
Lavie C, Rollot F, Durand-Dubief F, Marignier R, Ionescu I, Casey R, Moreau T, Tourniaire P, Hutchinson M, D'Hooghe MB, Laplaud DA, Clavelou P, De Sèze J, Debouverie M, Brassat D, Pelletier J, Lebrun-Frenay C, Le Page E, Castelnovo G, Berger E, Hautecoeur P, Heinzlef O, Durelli L, Clerico M, Trojano M, Patti F, Vukusic S; PRIMS and POPARTMUS investigators. Lavie C, et al. Mult Scler. 2019 Apr;25(4):591-600. doi: 10.1177/1352458518763080. Epub 2018 Mar 20. Mult Scler. 2019. PMID: 31081475 Free article. Clinical Trial.
41 results